Ali Moshfegh
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Hematology 13
- Hematopoietic Stem Cell Transplantation 4
- Genetics 12
- Chronic Lymphocytic Leukemia Research 12
- Co-authors
- Håkan MellstedtVladimir J.N. BykovKlas G. WimanJoachim LundahlMohammad Hojjat‐FarsangiAnders ÖsterborgAmir Hossein DaneshmaneshSören Lehmann
In The Last Decade
Ali Moshfegh
60 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Oncology 524
- Hematology 178
- Cancer Research 226
- Immunology 304
- Genetics 121
Countries citing papers authored by Ali Moshfegh
This map shows the geographic impact of Ali Moshfegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Moshfegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Moshfegh more than expected).
Fields of papers citing papers by Ali Moshfegh
This network shows the impact of papers produced by Ali Moshfegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Moshfegh. The network helps show where Ali Moshfegh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ali Moshfegh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2017 | 1 | |
| 3 | 2016 | 23 | |
| 4 | 2016 | 3 | |
| 5 | 2016 | 6 | |
| 6 | 2016 | 26 | |
| 7 | 2015 | 13 | |
| 8 | 2015 | 24 | |
| 9 | 2013 | 21 | |
| 10 | 2013 | 21 | |
| 11 | 2013 | 13 | |
| 12 | 2012 | 7 | |
| 13 | 2011 | 13 | |
| 14 | 2010 | 26 | |
| 15 | 2009 | 85 | |
| 16 | 2007 | 5 | |
| 17 | 2007 | 73 | |
| 18 | 2004 | 60 | |
| 19 | 2002 | 8 | |
| 20 | 2001 | 7 |
About Ali Moshfegh
Ali Moshfegh is a scholar working on Hematology, Genetics, Immunology, Nephrology and Oncology, having authored 60 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Wnt/β-catenin signaling in development and cancer (9 papers), Immune Cell Function and Interaction (7 papers), Galectins and Cancer Biology (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Dialysis and Renal Disease Management (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Oncology (524 citations), Hematology (178 citations), Cancer Research (226 citations), Immunology (304 citations) and Genetics (121 citations). Ali Moshfegh has collaborated with scholars based in Sweden, Iran and Greece. Frequent co-authors include Håkan Mellstedt, Vladimir J.N. Bykov, Klas G. Wiman, Joachim Lundahl, Mohammad Hojjat‐Farsangi, Anders Österborg, Amir Hossein Daneshmanesh, Sören Lehmann, Dina Ali and Ove Andrén. Their work appears in journals such as PLoS ONE, Blood, Journal of Clinical Oncology, Leukemia and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.